0001881936-25-000002.txt : 20251120 0001881936-25-000002.hdr.sgml : 20251120 20251120135448 ACCESSION NUMBER: 0001881936-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251120 DATE AS OF CHANGE: 20251120 EFFECTIVENESS DATE: 20251120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ECLIPSE BIOINNOVATIONS, INC. CENTRAL INDEX KEY: 0001881936 ORGANIZATION NAME: EIN: 822088549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-564566 FILM NUMBER: 251502333 BUSINESS ADDRESS: STREET 1: 6195 CORNERSTONE COURT EAST, #105 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-255-8115 MAIL ADDRESS: STREET 1: 6195 CORNERSTONE COURT EAST, #105 CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001881936 ECLIPSE BIOINNOVATIONS, INC. 5770 Oberlin Dr. SAN DIEGO CA CALIFORNIA 92121 (858) 768-0699 DELAWARE None None Corporation true Peter Chu c/o Eclipse BioInnovations, Inc. 5770 Oberlin Dr. San Diego CA CALIFORNIA 92121 Executive Officer Director Edmond Wong c/o Eclipse BioInnovations, Inc. 5770 Oberlin Dr. San Diego CA CALIFORNIA 92121 Director Daniel Vasella c/o Eclipse BioInnovations, Inc. 5770 Oberlin Dr. San Diego CA CALIFORNIA 92121 Director Eugene Yeo c/o Eclipse BioInnovations, Inc. 5770 Oberlin Dr. San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b false 2025-11-05 false true false 0 7235074 4905886 2329188 Total Amount Sold includes $4,235,076.39 of cancellation of convertible securities and $670,809.39 of new cash. false 7 0 0 0 false ECLIPSE BIOINNOVATIONS, INC. /s/ Peter Chu Peter Chu Chief Executive Officer 2025-11-20